ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis
NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
Taking everything into account, ARDT scores 5 out of 10 in our fundamental rating. ARDT was compared to 103 industry peers in the Health Care Providers & Services industry. ARDT has an average financial health and profitability rating. ARDT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year ARDT was profitable.
In the past year ARDT had a positive cash flow from operations.
1.2 Ratios
ARDT has a better Return On Assets (4.57%) than 76.70% of its industry peers.
ARDT has a Return On Equity of 19.12%. This is amongst the best in the industry. ARDT outperforms 86.41% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.15%, ARDT is in the better half of the industry, outperforming 75.73% of the companies in the same industry.
ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.71%.
The 3 year average ROIC (5.96%) for ARDT is below the current ROIC(8.15%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 19.12% | ||
| ROIC | 8.15% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
ARDT's Profit Margin of 3.73% is fine compared to the rest of the industry. ARDT outperforms 70.87% of its industry peers.
In the last couple of years the Profit Margin of ARDT has grown nicely.
Looking at the Operating Margin, with a value of 6.59%, ARDT is in the better half of the industry, outperforming 68.93% of the companies in the same industry.
ARDT's Operating Margin has improved in the last couple of years.
ARDT's Gross Margin of 57.32% is fine compared to the rest of the industry. ARDT outperforms 78.64% of its industry peers.
In the last couple of years the Gross Margin of ARDT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | 3.73% | ||
| GM | 57.32% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ARDT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ARDT has been increased compared to 1 year ago.
The debt/assets ratio for ARDT has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.17 indicates that ARDT is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARDT has a Altman-Z score (2.17) which is comparable to the rest of the industry.
The Debt to FCF ratio of ARDT is 9.36, which is on the high side as it means it would take ARDT, 9.36 years of fcf income to pay off all of its debts.
ARDT has a Debt to FCF ratio (9.36) which is in line with its industry peers.
A Debt/Equity ratio of 0.93 indicates that ARDT is somewhat dependend on debt financing.
The Debt to Equity ratio of ARDT (0.93) is worse than 63.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 9.36 | ||
| Altman-Z | 2.17 |
ROIC/WACC1
WACC8.15%
2.3 Liquidity
ARDT has a Current Ratio of 2.12. This indicates that ARDT is financially healthy and has no problem in meeting its short term obligations.
ARDT's Current ratio of 2.12 is fine compared to the rest of the industry. ARDT outperforms 75.73% of its industry peers.
ARDT has a Quick Ratio of 1.98. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
ARDT's Quick ratio of 1.98 is fine compared to the rest of the industry. ARDT outperforms 75.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 314.38% over the past year.
ARDT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.75% yearly.
Looking at the last year, ARDT shows a quite strong growth in Revenue. The Revenue has grown by 10.29% in the last year.
The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%53.26%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%4.04%
3.2 Future
ARDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
Based on estimates for the next years, ARDT will show a small growth in Revenue. The Revenue will grow by 6.52% on average per year.
EPS Next Y58.8%
EPS Next 2Y29.01%
EPS Next 3Y23.19%
EPS Next 5YN/A
Revenue Next Year8.36%
Revenue Next 2Y6.95%
Revenue Next 3Y6.52%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ARDT is valuated reasonably with a Price/Earnings ratio of 9.00.
Based on the Price/Earnings ratio, ARDT is valued cheaper than 94.17% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.51, ARDT is valued rather cheaply.
The Price/Forward Earnings ratio is 7.08, which indicates a rather cheap valuation of ARDT.
Based on the Price/Forward Earnings ratio, ARDT is valued cheaply inside the industry as 97.09% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 35.58. ARDT is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9 | ||
| Fwd PE | 7.08 |
4.2 Price Multiples
91.26% of the companies in the same industry are more expensive than ARDT, based on the Enterprise Value to EBITDA ratio.
67.96% of the companies in the same industry are more expensive than ARDT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.51 | ||
| EV/EBITDA | 4.94 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARDT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ARDT's earnings are expected to grow with 23.19% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y29.01%
EPS Next 3Y23.19%
5. Dividend
5.1 Amount
No dividends for ARDT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.49
+0.32 (+2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.26%
Inst Owner Change0%
Ins Owners1.98%
Ins Owner Change1.21%
Market Cap2.07B
Analysts82.35
Price Target20.66 (42.58%)
Short Float %1.52%
Short Ratio5.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)59.62%
Min EPS beat(2)43.05%
Max EPS beat(2)76.2%
EPS beat(4)3
Avg EPS beat(4)21.25%
Min EPS beat(4)-44.28%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.04%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)6.1%
Revenue beat(4)1
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.41%
PT rev (3m)-5.08%
EPS NQ rev (1m)-7.6%
EPS NQ rev (3m)-12.38%
EPS NY rev (1m)0.23%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9 | ||
| Fwd PE | 7.08 | ||
| P/S | 0.34 | ||
| P/FCF | 17.51 | ||
| P/OCF | 6.8 | ||
| P/B | 1.76 | ||
| P/tB | 9.35 | ||
| EV/EBITDA | 4.94 |
EPS(TTM)1.61
EY11.11%
EPS(NY)2.05
Fwd EY14.13%
FCF(TTM)0.83
FCFY5.71%
OCF(TTM)2.13
OCFY14.71%
SpS42.12
BVpS8.22
TBVpS1.55
PEG (NY)0.15
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 19.12% | ||
| ROCE | 9.73% | ||
| ROIC | 8.15% | ||
| ROICexc | 9.28% | ||
| ROICexgc | 12.64% | ||
| OM | 6.59% | ||
| PM (TTM) | 3.73% | ||
| GM | 57.32% | ||
| FCFM | 1.96% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 9.36 | ||
| Debt/EBITDA | 2 | ||
| Cap/Depr | 126.81% | ||
| Cap/Sales | 3.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.04% | ||
| Profit Quality | 52.68% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.98 | ||
| Altman-Z | 2.17 |
F-Score8
WACC8.15%
ROIC/WACC1
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%53.26%
EPS Next Y58.8%
EPS Next 2Y29.01%
EPS Next 3Y23.19%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%4.04%
Revenue Next Year8.36%
Revenue Next 2Y6.95%
Revenue Next 3Y6.52%
Revenue Next 5YN/A
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year71.17%
EBIT Next 3Y25.43%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A